0.000USD0.000盤前交易 07/24, 09:30 (美東)
Pacific Biosciences of California Inc
關鍵數據
1.360今開
1.430最高
6.86M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
2.21%換手率
1.380昨收
1.360最低
7.58M成交額
虧損本益比靜
183.06市淨率
0.00%股息率 TTM
-15.65%ROA
2.73052週最高
0.92量比
-309.85M淨利潤
310.49M總股本
-0.4133每股盈餘TTM
2.36Beta
-273.55%ROE
0.96052週最低
5.07%振幅
32.30%毛利率
433.13M總市值
-0.82回報/風險
5.08%風險率
操作建議
Pacific Biosciences of California Inc當前公司基本面數據相對謹慎,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名108/200位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為2.46。中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Pacific Biosciences of California Inc評分
壓力支撐

由於公司未披露,未能獲取相關數據
Pacific Biosciences of California Inc亮點
亮點風險
Pacific Biosciences of California Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Pacific Biosciences of California Inc
PACB
8
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Pacific Biosciences of California Inc簡介
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
公司代碼PACB
公司Pacific Biosciences of California Inc
CEOHenry (Christian O)
網址https://www.pacb.com/
公司股東
常見問題
Pacific Biosciences of California Inc(PACB)的當前股價是多少?
Pacific Biosciences of California Inc(PACB)的當前股價是 1.40。
Pacific Biosciences of California Inc 的股票代碼是什麼?
Pacific Biosciences of California Inc的股票代碼是PACB。
Pacific Biosciences of California Inc股票的52週最高點是多少?
Pacific Biosciences of California Inc股票的52週最高點是2.73。
Pacific Biosciences of California Inc股票的52週最低點是多少?
Pacific Biosciences of California Inc股票的52週最低點是0.96。
Pacific Biosciences of California Inc的市值是多少?
Pacific Biosciences of California Inc的市值是433.13M。
現在Pacific Biosciences of California Inc(PACB)的股票是買入、持有還是賣出?
根據分析師評級,Pacific Biosciences of California Inc(PACB)的總體評級為買入,目標價格為2.46。
Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是多少
Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是-1.82。